Skip to content

Accepting participants

Trials recruiting now

These trials were accepting participants at the last data build. Participation is free, and for many people a trial is the only lawful route to these treatments. Eligibility is decided by each trial’s investigators at a screening visit.

218
Trials listed
218
Recruiting
24
In Phase 3
0
With results posted
TrialStatusPhaseSubstanceSites
Positioning of Esketamine Treatment in the Real-world Management of DepressionNCT06103760 · Royal North Shore HospitalRecruitingPhase 4ketamine1
Esketamine Versus Crisis Response Planning Versus Optimized Treatment as Usual for Suicide Prevention: A Pragmatic Controlled Trial in Two Brazilian CitiesNCT07120477 · University of Sao PauloRecruitingPhase 4ketamine1
Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm RepairNCT04894864 · University of CreteRecruitingPhase 4ketamine1
Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-resistant DepressionNCT06278779 · The George InstituteRecruitingPhase 4ketamine7
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma PatientsNCT06903819 · Texas Tech University Health Sciences CenterRecruitingPhase 4ketamine2
Esketamine With or Without Integration Therapy for Treatment-Resistant DepressionNCT07369102 · University of Puerto RicoRecruitingPhase 4ketamine2
Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With DepressionNCT05450432 · Massachusetts General HospitalRecruitingPhase 4ketamine1
Determination of ED50 and ED95 With Clinical Efficacy of Intranasal Dexmedetomidine Combined With Esketamine for Preoperative Sedation in Pediatric General AnesthesiaNCT06853431 · Second Affiliated Hospital of Wenzhou Medical UniversityRecruitingPhase 4ketamine2
Neural Circuit Effects of Ketamine in DepressionNCT06213324 · Icahn School of Medicine at Mount SinaiRecruitingPhase 4ketamine1
Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECTNCT05655754 · Medical University of ViennaRecruitingPhase 4ketamine1
Analgesic Efficacy of Intravenous Ketamine as a Continuous Infusion vs PCA in the Management of Acute Postoperative Pain in Major Orthopedic Surgery.NCT06774274 · Universidad de AntioquiaRecruitingPhase 4ketamine1
The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSDNCT06414356 · Margaux M. Salas, PhDRecruitingPhase 4ketamine1
ECT with Ketamine Anesthesia Vs High Intensity Ketamine with ECT Rescue for Treatment-Resistant DepressionNCT03272698 · University of SaskatchewanRecruitingPhase 4ketamine1
IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric EDNCT05934669 · University of OklahomaRecruitingPhase 4ketamine1
Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderNCT07570654 · COMPASS PathwaysRecruitingPhase 2 / Phase 3psilocybin1
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderNCT06793397 · Cybin IRL LimitedRecruitingPhase 3psilocybin68
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant DepressionNCT07226232 · VA Office of Research and DevelopmentRecruitingPhase 3psilocybin5
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive DisorderNCT06247839 · Sharmin GhaznaviRecruitingPhase 3psilocybin1
InTRavenous kEtAmine and immerSive virtUal Reality to Treat dEpressionNCT06781697 · Sunnybrook Health Sciences CentreRecruitingPhase 3ketamine1
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)NCT07592689 · Definium Therapeutics US, Inc.RecruitingPhase 3lsd30
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence StudyNCT06713616 · Yale UniversityRecruitingPhase 3ketamine8
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive DisorderNCT07227454 · Janssen Research & Development, LLCRecruitingPhase 3ketamine35
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant DepressionNCT07716098 · Janssen Research & Development, LLCRecruitingPhase 3ketamine4
Ketamine Treatment of Youth Suicide AttemptersNCT04763343 · Tatiana Falcone, MDRecruitingPhase 3ketamine1
Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Major Depressive DisorderNCT07703722 · Khyber Medical University PeshawarRecruitingPhase 3psilocybin3
Psilocybin Microdose for Psychological and Existential Distress in Palliative Care (PSYCHED-PAL-RCT)NCT07063862 · Bruyère Health Research Institute.RecruitingPhase 3psilocybin7
Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive SymptomsNCT07638553 · Centre Hospitalier Universitaire de NīmesRecruitingPhase 3psilocybin8
MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use DisorderNCT07118839 · VA Office of Research and DevelopmentRecruitingPhase 2 / Phase 3mdma2
Understanding and Treating Suicidal Ideation With KetamineNCT06891300 · The Royal's Institute of Mental Health ResearchRecruitingPhase 2 / Phase 3ketamine1
Ketamine Augmentation of ECT in Treatment-Resistant DepressionNCT07088380 · Università Vita-Salute San RaffaeleRecruitingPhase 3ketamine1
MDMA-assisted Massed Prolonged Exposure for PTSDNCT06117306 · Healing BreakthroughRecruitingPhase 3mdma1
Nebulized Ketamine for the Treatment of Major Depressive DisorderNCT06752759 · Theresa Jacob, PhD, MPHRecruitingPhase 3ketamine1
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment FailureNCT05603104 · Dr. Inge WinterRecruitingPhase 3ketamine1
Psilocybin Therapy in Advanced CancerNCT05398484 · NYU Langone HealthRecruitingPhase 2 / Phase 3psilocybin2
The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.NCT05973851 · Dr. Inge WinterRecruitingPhase 3ketamine12
Early Effects of Ketamine vs Placebo With Venlafaxine in Severe Depression PatientsNCT06508710 · Assistance Publique - Hôpitaux de ParisRecruitingPhase 3ketamine4
Ketamine & Crisis Response Plan for Suicidal Ideation in the EDNCT05696691 · The University of Texas Health Science Center at San AntonioRecruitingPhase 2 / Phase 3ketamine1
Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and Moral InjuryNCT06394284 · Herzog HospitalRecruitingPhase 3mdma1
Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant DepressionNCT07211438 · Centre for Addiction and Mental HealthRecruitingPhase 2psilocybin2
MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress DisorderNCT05790239 · Stephen Robert MarderRecruitingPhase 2mdma2
MDMA-Assisted CBCT for PTSD vs CBCT RCTNCT06044675 · RemedyRecruitingPhase 2mdma1
Neurobiology of SuicideNCT02543983 · National Institute of Mental Health (NIMH)RecruitingPhase 2ketamine1
Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia NervosaNCT07169747 · Region SkaneRecruitingPhase 2psilocybin1
Psilocybin-Assisted Therapy for Intergenerational TraumaNCT06899165 · Rachel YehudaRecruitingPhase 2psilocybin1
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance TherapyNCT06200155 · M.D. Anderson Cancer CenterRecruitingPhase 2psilocybin1
Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUDNCT06349083 · NYU Langone HealthRecruitingPhase 2psilocybin1
Pilot Study of RR-HNK in OCDNCT06575075 · Carolyn RodriguezRecruitingPhase 1 / Phase 2ketamine1
Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and SuicidalityNCT06706232 · The University of Texas Health Science Center, HoustonRecruitingPhase 2psilocybin1
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer SurvivorsNCT06801041 · M.D. Anderson Cancer CenterRecruitingPhase 2psilocybin1
Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety DisorderNCT06969170 · Claudio N SoaresRecruitingPhase 2psilocybin1
Investigation to Understand and Optimize PsilocybinNCT06512194 · Charles RaisonRecruitingPhase 2psilocybin1
Psilocybin to Treat Depression in Spinal Cord InjuryNCT07251491 · James J. Peters Veterans Affairs Medical CenterRecruitingPhase 1 / Phase 2psilocybin1
Psilocybin Therapy for Depression in Parkinson's DiseaseNCT06455293 · Joshua Woolley, MD, PhDRecruitingPhase 2psilocybin1
Mindfulness-Assisted Psychedelic TherapyNCT06233344 · University of Southern CaliforniaRecruitingPhase 2psilocybin1
Psilocybin in Cancer Pain StudyNCT06001749 · Yvan Beaussant, MD, MSciRecruitingPhase 2psilocybin1
Effects of a Sigle Dose of Ayahuasca in Patients With Psychogenic Non-epileptic Seizures: an Open Label Clinical TrialNCT07747324 · University of Sao PauloRecruitingPhase 1 / Phase 2dmt1
Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)NCT06512220 · Centre for Addiction and Mental HealthRecruitingPhase 2psilocybin1
Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)NCT06518720 · Centre for Addiction and Mental HealthRecruitingPhase 2psilocybin1
Ecstasy to Alleviate SEvere Chronic Neuropathic Pain TrialNCT07301632 · Unity Health TorontoRecruitingPhase 2mdma1
Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)NCT07569198 · Joshua RosenblatRecruitingPhase 2ketamine1
Effects of Psilocybin on Electrophysiology and the Dynamic Content of ThoughtNCT05301608 · Johns Hopkins UniversityRecruitingPhase 1 / Phase 2psilocybin1
A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and AnxietyNCT06820723 · Ohio State UniversityRecruitingPhase 2psilocybin1
Psilocybin-Assisted Therapy for Physician Well-Being and BurnoutNCT06814522 · University of California, San DiegoRecruitingPhase 1 / Phase 2psilocybin1
Psilocybin Efficacy With or Without Pimavanserin PretreatmentNCT07610135 · Johns Hopkins UniversityRecruitingPhase 1 / Phase 2psilocybin1
The Efficacy of Psilocybin Therapy for Depression in Parkinson's DiseaseNCT07610369 · Yale UniversityRecruitingPhase 2psilocybin1
Tolerability of MDMA in SchizophreniaNCT05770375 · Anya Bershad, MD, PhDRecruitingPhase 1 / Phase 2mdma1
Outpatient Buprenorphine Induction With Psilocybin for Opioid Use DisorderNCT06067737 · Johns Hopkins UniversityRecruitingPhase 2psilocybin1
Inhaled DMT for Major Depressive DisorderNCT07562191 · Universidade Federal do Rio Grande do NorteRecruitingPhase 2dmt5
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant DepressionNCT06511908 · National Institute of Mental Health (NIMH)RecruitingPhase 2ketamine1
Psilocybin on Brain Mechanisms of Motivation in OUDNCT06810310 · University of PennsylvaniaRecruitingPhase 2psilocybin1
Preliminary Effectiveness of Individual and Group MDMA-assisted Therapy for Israeli Veterans With PTSD and Moral Injury.NCT05732155 · HaEmek Medical Center, IsraelRecruitingPhase 2mdma1
Psilocybin-Assisted Therapy for Sexual Assault-Related PTSDNCT06902974 · Sunstone MedicalRecruitingPhase 2psilocybin1
MDMA Therapy in Veterans With PTSDNCT07569159 · Sunstone MedicalRecruitingPhase 2mdma1
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use DisorderNCT05452772 · Johns Hopkins UniversityRecruitingPhase 2psilocybin3
Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSDNCT06386003 · Unity Health TorontoRecruitingPhase 2psilocybin1
Mindfulness-based Psilocybin Therapy for PTSDNCT07104916 · Anthony P KingRecruitingPhase 2psilocybin1
Ketamine for Combined Depression and Alcohol Use DisorderNCT06090422 · University Hospital of North NorwayRecruitingPhase 1 / Phase 2ketamine1
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Caregivers of Patients With Advanced CancerNCT07048743 · University Health Network, TorontoRecruitingPhase 2psilocybin1
Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit PatientsNCT07639359 · Hospital Italiano de Buenos AiresRecruitingPhase 2ketamine2
Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy VolunteersNCT06626139 · Robin Carhart-Harris, PhD, MARecruitingPhase 2psilocybin1
Subjective Experience Following PsilocybinNCT06768944 · University of CalgaryRecruitingPhase 2psilocybin1
MDMA-Assisted Massed Exposure Therapy for PTSDNCT07288151 · Emory UniversityRecruitingPhase 2mdma1
Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung CancerNCT07216404 · Alan DavisRecruitingPhase 2psilocybin1
Psilocybin Therapy for Psychological Distress in Palliative PatientsNCT06782724 · University Medical Center GroningenRecruitingPhase 2psilocybin4
The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal EffectsNCT05786066 · Yale UniversityRecruitingPhase 2ketamine1
MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant OtherNCT05584826 · Sunstone MedicalRecruitingPhase 2mdma1
Ketamine Alcohol (in Treatment-Resistant Depression)NCT02122562 · Mark NiciuRecruitingPhase 2ketamine1
Ketamine, SGB and Combination Treatment for TBI-associated Headache or PTSDNCT06608277 · Northwestern UniversityRecruitingPhase 2ketamine3
LSD Treatment for Persons With Alcohol Use DisorderNCT05474989 · Felix MuellerRecruitingPhase 2lsd2
Lysergic Acid Diethylamide (LSD) in Palliative CareNCT05883540 · University Hospital, Basel, SwitzerlandRecruitingPhase 2lsd4
Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)NCT05940324 · Stanford UniversityRecruitingPhase 2ketamine1
Cancer Related Major Depression Treated With a Single Dose of PsilocybinNCT06319378 · Section for Affective Disorders; Northern Stockholm PsychiatryRecruitingPhase 2psilocybin4
A Phase 2A Trial of DT402 for Autism Spectrum DisorderNCT07303907 · Definium Therapeutics US, Inc.RecruitingPhase 2mdma1
A Randomized Neuroimaging Trial of Psilocybin in DepressionNCT06072898 · Sunnybrook Health Sciences CentreRecruitingPhase 2psilocybin1
Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory DepressionNCT06898606 · Federal University of Latin American IntegrationRecruitingPhase 1 / Phase 2psilocybin1
MDMA for Co-occurring PTSD and OUD After ChildbirthNCT05219175 · University of New MexicoRecruitingPhase 2mdma1
Ketamine for Opioid Use DisorderNCT06943859 · University of Maryland, BaltimoreRecruitingPhase 2ketamine1
Group vs Individual MDMA-Assisted Therapy for PTSD After the October 7, 2023 EventsNCT07469098 · Sheba Medical CenterRecruitingPhase 2mdma2
Imaging Depression in Parkinson's DiseaseNCT06402955 · Yale UniversityRecruitingPhase 2ketamine1
MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)NCT05783817 · Carolyn RodriguezRecruitingPhase 2mdma1
Study of Psilocybin for Anorexia in Young AdultsNCT06399263 · Marissa Raymond-Flesch, MD, MPHRecruitingPhase 2psilocybin2
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment DisorderNCT07072728 · Psyence Australia Pty LtdRecruitingPhase 2psilocybin3
RCT of Psilocybin-assisted CBT for DepressionNCT07281352 · University of California, Los AngelesRecruitingPhase 1 / Phase 2psilocybin1
Psilocybin for Opioid Use Disorder (OUD)NCT06796062 · NYU Langone HealthRecruitingPhase 2psilocybin5
MDMA in Borderline Personality DisorderNCT06683014 · Yale UniversityRecruitingPhase 2mdma1
State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing TraumaNCT06888128 · Baylor College of MedicineRecruitingPhase 2psilocybin1
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or BehaviorNCT07193901 · Sichuan Purity Pharmaceutical Technology Co., Ltd.RecruitingPhase 2ketamine8
Ayahuasca, Esketamine and PTSDNCT07317206 · University of Sao PauloRecruitingPhase 2ketamine, dmt1
Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid DepressionNCT06419439 · VA Office of Research and DevelopmentRecruitingPhase 2ketamine1
i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical TrialNCT06480500 · University Health Network, TorontoRecruitingPhase 2ketamine1
Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol Use DisorderNCT06969937 · Dr. med. Marcus HerdenerRecruitingPhase 2ketamine1
Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid MedicationNCT05585229 · University of British ColumbiaRecruitingPhase 2psilocybin1
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator TrialNCT06405607 · University of IowaRecruitingPhase 2psilocybin, ketamine1
Psilocybin rTMS for Treatment Resistant DepressionNCT06132178 · University of Texas at AustinRecruitingPhase 2psilocybin1
Pragmatic Trial of Psilocybin Therapy in Palliative CareNCT05403086 · Charles S. Grob, M.D.RecruitingPhase 2psilocybin, ketamine5
Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCDNCT04882839 · Beersheva Mental Health CenterRecruitingPhase 2psilocybin1
Psilocybin Microdosing With Psychotherapy for Treatment-Resistant DepressionNCT07183748 · Beersheva Mental Health CenterRecruitingPhase 2psilocybin1
Wellcome Leap Psilocybin for OUDNCT06786325 · Anna Rose Childress, Ph.D.RecruitingPhase 2psilocybin1
Intravenous Ketamine for Treatment-Resistant DepressionNCT06668571 · Mayo ClinicRecruitingPhase 2ketamine1
MDMA-assisted Cognitive Processing Therapy Versus Cognitive Processing Therapy for Veterans With Severe Posttraumatic Stress DisorderNCT05837845 · Patricia SuppesRecruitingPhase 2mdma1
A Ketamine-assisted Group Therapy Intervention for Spanish-speaking Adults With DepressionNCT06597695 · Juliana Zambrano, MD, MPHRecruitingPhase 1 / Phase 2ketamine1
Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of DepressionNCT06559826 · Icahn School of Medicine at Mount SinaiRecruitingPhase 2ketamine1
Dose Optimization of MDMA-Assisted Therapy for PTSDNCT06418178 · Bronx VA Medical CenterRecruitingPhase 2mdma1
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive DisorderNCT06592833 · Icahn School of Medicine at Mount SinaiRecruitingPhase 2psilocybin1
Enhancing Week-long Psychological Treatment for PTSD With KetamineNCT05737693 · Yale UniversityRecruitingPhase 2ketamine2
LSD to Improve Cluster Headache Impact TrialNCT05477459 · Radboud University Medical CenterRecruitingPhase 2lsd2
Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAINNCT06731335 · Unity Health TorontoRecruitingPhase 2psilocybin2
Pharmacologic Treatment Augmentation in Chronic DepressionNCT06410599 · University Hospital TuebingenRecruitingPhase 2ketamine2
Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept StudyNCT06225232 · McMaster UniversityRecruitingPhase 2psilocybin1
MDMA for AUD/PTSD ComorbidityNCT05943665 · Carolina L Haass-KofflerRecruitingPhase 2mdma1
Lysergic Acid Diethylamide (LSD) as Treatment for Cluster HeadacheNCT03781128 · University Hospital, Basel, SwitzerlandRecruitingPhase 2lsd1
Psilocybin for Hospitalized Patients with Treatment-resistant DepressionNCT06378229 · University Hospital, GhentRecruitingPhase 2psilocybin1
Psilocybin-Assisted Therapy for Severe Alcohol Use DisorderNCT06160232 · Brugmann University HospitalRecruitingPhase 2psilocybin1
Psilocybin-Assisted Psychotherapy for Alcohol Use DisorderNCT05995769 · University of CalgaryRecruitingPhase 2psilocybin1
The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)NCT06070649 · Yale UniversityRecruitingPhase 1dmt1
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive DisorderNCT03065335 · National Institute of Mental Health (NIMH)RecruitingPhase 1ketamine1
The RECAP2 Study: Midazolam and PsilocybinNCT06692192 · University of Wisconsin, MadisonRecruitingPhase 1psilocybin1
Safety and Tolerability Trial of Psilocybin in Healthy Older AdultsNCT07516405 · University of Colorado, DenverRecruitingPhase 1psilocybin6
The ENHANCE Study: taVNS and PsilocybinNCT05866471 · University of Wisconsin, MadisonRecruitingPhase 1psilocybin1
Psilocybin in Chronic Low Back Pain and DepressionNCT06355414 · Johns Hopkins UniversityRecruitingPhase 1psilocybin1
Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.NCT07347405 · Francisco A MorenoRecruitingPhase 1psilocybin1
Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the BrainNCT05265546 · University of California, BerkeleyRecruitingPhase 1psilocybin1
Adjunctive Effects of Psilocybin and a Formulation of BuprenorphineNCT04161066 · University of Wisconsin, MadisonRecruitingPhase 1psilocybin1
Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)NCT06160284 · Yale UniversityRecruitingPhase 1psilocybin1
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant DepressionNCT06480201 · Texas A&M UniversityRecruitingPhase 1ketamine2
MDMA Assisted Therapy for BNNCT07542145 · Icahn School of Medicine at Mount SinaiRecruitingPhase 1mdma1
Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major DepressionNCT03973268 · National Institute of Mental Health (NIMH)RecruitingPhase 1ketamine1
Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in HumansNCT06671977 · Deepak C. D'SouzaRecruitingPhase 1dmt1
A Study of Psychedelics in Healthy Older Adults With Low Well-beingNCT07386730 · Jennifer MitchellRecruitingPhase 1psilocybin1
Group Psilocybin-Assisted Therapy for Post-Traumatic Stress DisorderNCT07506395 · University of New MexicoRecruitingPhase 1psilocybin1
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine ResponseNCT05915013 · Yale UniversityRecruitingPhase 1ketamine1
HNC: Human Neural Circuits Electrophysiology During CognitionNCT05962424 · Stanford UniversityRecruitingPhase 1ketamine1
Study of Psilocybin Assisted Psychotherapy to Address Fear of RecurrenceNCT06430541 · University of Colorado, DenverRecruitingPhase 1psilocybin2
Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency DepartmentNCT06085937 · Lindsay Maguire, MDRecruitingPhase 1ketamine2
MDMA-Assisted Therapy for Mental Healthcare ProvidersNCT07102576 · Rachel YehudaRecruitingPhase 1mdma1
Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy ParticipantsNCT07494214 · University Hospital, Basel, SwitzerlandRecruitingPhase 1mdma1
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic EffectsNCT07490353 · Medical University of ViennaRecruitingPhase 1psilocybin1
Psilocybin-assisted Treatment for Cannabis Use DisorderNCT06660381 · Johns Hopkins UniversityRecruitingPhase 1psilocybin1
Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage CancerNCT06818994 · Gustavo VazquezRecruitingPhase 1psilocybin1
Open-Label Psilocybin Study in Transdiagnostic PopulationNCT06442423 · Yale UniversityRecruitingPhase 1psilocybin1
Acute Effects of Intravenous 5-MeO-DMT in Healthy ParticipantsNCT07444788 · University Hospital, Basel, SwitzerlandRecruitingPhase 1dmt1
Investigation of Psychedelic Effects in Psychoactive SubstancesNCT06772753 · Johns Hopkins UniversityRecruitingPhase 1psilocybin, mdma, dmt1
Psychedelic Healing: Adjunct Therapy Harnessing Opened MalleabilityNCT07053917 · Johns Hopkins UniversityRecruitingPhase 1psilocybin1
Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy VolunteersNCT07079930 · Hadassah Medical OrganizationRecruitingPhase 1psilocybin1
Treatment of Persisting Symptoms After Concussion With Psilocybin Assisted TherapyNCT06615908 · University of CalgaryRecruitingPhase 1psilocybin1
Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based ProgramsNCT06815653 · University College, LondonRecruitingPhase 1psilocybin1
Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older AdultsNCT06367738 · University of California, BerkeleyRecruitingPhase 1psilocybin1
Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)NCT06989957 · Johns Hopkins UniversityRecruitingPhase 1psilocybin, mdma1
Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of ConsciousnessNCT06796361 · University Hospital, Basel, SwitzerlandRecruitingPhase 1psilocybin1
Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in Healthy ParticipantsNCT06899334 · University Hospital, Basel, SwitzerlandRecruitingPhase 1lsd, psilocybin, dmt1
The Neurobiological Effect of 5-HT2AR ModulationNCT03289949 · Gitte Moos KnudsenRecruitingPhase 1psilocybin1
Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy SubjectsNCT06511947 · GH Research Ireland LimitedRecruitingPhase 1dmt1
Psilocybin Administration With 5-HT1a BlockadeNCT07565493 · Johns Hopkins UniversityRecruitingEarly Phase 1psilocybin1
Effects of Psilocybin in Patients With Amyotrophic Lateral SclerosisNCT06656702 · Johns Hopkins UniversityRecruitingEarly Phase 1psilocybin1
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of KetamineNCT06788249 · University of PennsylvaniaRecruitingEarly Phase 1ketamine1
Psilocybin as a Treatment for Chronic Pain in SmokersNCT07118332 · Yale UniversityRecruitingEarly Phase 1psilocybin2
Trauma-informed Psilocybin Assisted Psychotherapy (TiPAP) for PTSDNCT07737054 · Tel-Aviv Sourasky Medical CenterRecruitingEarly Phase 1psilocybin1
Changes in Self-awareness Induced by Psychoactive Substances: an Experimental Study With Psilocybin.NCT07732166 · Pontifícia Universidade Católica do Rio de JaneiroRecruitingEarly Phase 1psilocybin1
Mechanistic Studies of Psilocybin in Headache DisordersNCT06464367 · Yale UniversityRecruitingEarly Phase 1psilocybin1
MDMA-assisted Therapy for FibromyalgiaNCT06066853 · Spaulding Rehabilitation HospitalRecruitingEarly Phase 1mdma1
Psilocybin for Prolonged Grief DisorderNCT06724289 · University of VirginiaRecruitingEarly Phase 1psilocybin1
Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With KetamineNCT05327699 · Emory UniversityRecruitingEarly Phase 1ketamine1
Personalized DBS Targeting for Treating DepressionNCT06784388 · Second Affiliated Hospital, Zhejiang University, School of MedicineRecruitingEarly Phase 1ketamine1
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's DiseaseNCT04123314 · Johns Hopkins UniversityRecruitingEarly Phase 1psilocybin1
Psilocybin-facilitated Treatment for Chronic PainNCT05068791 · University of Alabama at BirminghamRecruitingEarly Phase 1psilocybin1
Subanesthetic Esketamine in Modified ECT for Severe Depression in Adolescents: Clinical and Mechanistic StudyNCT07247968 · Min SuRecruitingEarly Phase 1ketamine2
PsiloIMAGINE: A Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harmNCT06798636 · Imperial College LondonRecruitingEarly Phase 1psilocybin1
Psilocybin for Methamphetamine AddictionNCT06899594 · Kevin MurnaneRecruitingEarly Phase 1psilocybin1
Cognitive Training as an Adjunct to Ketamine in Real-world ClinicsNCT06526078 · University of PittsburghRecruitingNot applicableketamine3
The OBSERVE ProtocolNCT06725277 · Yale UniversityRecruitingN/Aketamine8
Coaching as an Adjunct to Ketamine Therapy for Treatment-Resistant DepressionNCT07563868 · Massachusetts General HospitalRecruitingNot applicableketamine2
Working Mechanisms and Effectiveness of IV Ketamine-assisted Psychotherapy on Depression in TRD ClientsNCT07706478 · SenzRecruitingN/Aketamine1
Mapping Ibogaine Neural Dynamics in Opioid Use DisorderNCT07226570 · University of California, IrvineRecruitingN/Aibogaine1
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1NCT07528014 · Salma Health, Inc.RecruitingN/Aketamine2
Belief Updating in Treatment Resistant DepressionNCT05577247 · Assistance Publique - Hôpitaux de ParisRecruitingN/Aketamine1
Retrospective Analyses of the Greenbrook Database Evaluating Mental Health TreatmentsNCT06997549 · NeuroneticsRecruitingN/Aketamine1
Antidepressant Response of DMT Masked With PropofolNCT06927076 · University Hospital, Basel, SwitzerlandRecruitingNot applicabledmt1
Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant DepressionNCT07146503 · Riccardo GuglielmoRecruitingN/Aketamine5
Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSDNCT07461532 · Northern Jiangsu People's HospitalRecruitingNot applicablelsd1
Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSDNCT07309471 · University Hospital, Basel, SwitzerlandRecruitingNot applicablelsd1
ACT_for Alcohol Use Disorder and DepressionNCT06620276 · Centre hospitalier de l'Université de Montréal (CHUM)RecruitingNot applicableketamine1
University of Iowa Interventional Psychiatry Service Patient RegistryNCT04480918 · Mark NiciuRecruitingN/Aketamine1
Virtual Reality-Based Mindfulness as an Adjunct to Treatment as Usual in Treatment-Resistant DepressionNCT07422519 · Hospital Universitari Vall d'Hebron Research InstituteRecruitingNot applicableketamine1
Ayahuasca, Esketamine and Body Image PerceptionNCT07317219 · University of Sao PauloRecruitingNot applicabledmt1
Ayahuasca, Esketamine and Premenstrual SymptomsNCT07317232 · University of Sao PauloRecruitingNot applicabledmt1
At-Home tDCS as Maintenance TherapyNCT07269964 · Technical University of MunichRecruitingNot applicableketamine2
The Impact of Psilocybin on Pain in Fibromyalgia PatientsNCT06368492 · Maastricht UniversityRecruitingNot applicablepsilocybin2
Ketamine in OCD: Efficacy and Effects on Stress and CognitionNCT05577585 · Medical University of ViennaRecruitingNot applicableketamine1
Metabolic Profiling of Esketamine Treatment in Depressive DisorderNCT07002684 · University of ZagrebRecruitingN/Aketamine1
Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy ControlsNCT06789705 · University Hospital, Basel, SwitzerlandRecruitingNot applicablemdma1
Veteran's Perceptions of Ketamine-Assisted Psychotherapy for Depression and End-of-LifeNCT06824532 · Albany Research Institute, Inc.RecruitingN/Aketamine1
Ketamine Enhances Analgesia and Mood in Chronic Pain PatientsNCT05985811 · Salem Anaesthesia Pain ClinicRecruitingN/Aketamine1
Digital Interventions for Adults with Treatment-Resistant Depression: a Pilot StudyNCT06732089 · Unity Health TorontoRecruitingN/Aketamine1
Dexmedetomidine and Ketamine in VATS SurgeryNCT03596424 · Ciusss de L'Est de l'Île de MontréalRecruitingNot applicableketamine1
Ketamine Treatment Plans for Chronic ConditionsNCT06038409 · RIVER FoundationRecruitingN/Aketamine1
RIVER At Home Ketamine ProtocolsNCT06070766 · RIVER FoundationRecruitingN/Aketamine2
Study of the Neural Circuits Underlying the Negative Emotional Bias of Depressive Disorders and Their Response to KetamineNCT06630065 · Centre Hospitalier St AnneRecruitingNot applicableketamine1
IV Ketamine vs. IN Esketamine for MDD TRDNCT06488586 · Gustavo VazquezRecruitingN/Aketamine1

All records from ClinicalTrials.gov API v2, data build 2026-08-25. Registry records change between builds; the NCT number on each row links to the authoritative version.